...that paragraph to me is more about the beneficial effect + outcome in early MPC treatment on limiting deleterious scar tissue replacement and subsequent reduction in LVEF rather than a description of specific MOA. I am intrigued by his reference to endothelium controlled signal pathways, disruption of which between endothelium and cardiocytes "has been implicated" in cardiac structural/functionsl abnormalities.
I guess I'm curious about MPC cardiac regenerative effects as well as immunomodulatory inflammatory effects that impede scar tissue + general degradation in myocardial function, control of which by itself may explain the beneficial results observed.
Nice. Thanks. More reading to do.
MSB's year is upon us. Strap in.
- Forums
- ASX - By Stock
- Ann: Half Year Financial Results Presentation
...that paragraph to me is more about the beneficial effect +...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.07 |
Change
-0.020(1.83%) |
Mkt cap ! $1.227B |
Open | High | Low | Value | Volume |
$1.10 | $1.10 | $1.06 | $4.276M | 3.987M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12409 | $1.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 17608 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12409 | 1.140 |
2 | 18423 | 1.125 |
4 | 42957 | 1.120 |
3 | 5072 | 1.100 |
6 | 23900 | 1.090 |
Price($) | Vol. | No. |
---|---|---|
0.935 | 40000 | 1 |
0.975 | 17608 | 1 |
1.000 | 19785 | 2 |
1.010 | 2499 | 2 |
1.015 | 372 | 1 |
Last trade - 15.59pm 20/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online